2025 MIDD Webinar Series | Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and  Novartis perspectives on this Model Informed Drug Development application

2025 MIDD Webinar Series | Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and Novartis perspectives on this Model Informed Drug Development application

The MIDD Webinar Series, coordinated by Yash Kapoor and Fulya Akpinar Singh, is a series of webinars focused on shaping the future of drug development and regulatory decision-making sponsored by the ISoP Education Committee. Topics range from MIDD approaches in regulatory submission to pharmacometrics topics that are at the core of model development.  

Key:

Complete
Failed
Available
Locked
MIDD Series: Approval of an intravenous secukinumab regimen not tested in clinical trial – FDA and Novartis perspectives on this Model Informed Drug Development application
03/19/2025 at 12:00 PM (EDT)  |  60 minutes
03/19/2025 at 12:00 PM (EDT)  |  60 minutes